ArticleMolecular and cellular biochemistry2026

EF-1α-driven nanobody-based CD19-redirected CAR-T cells retain the antitumor efficacy, antigen-driven expansion, and cytokine secretion of CMV-driven counterparts.

Marzieh Mazinani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.